Scientific Contributions
Lessons Learned With Carlo Toniatti

IRBM’s Chief Science Officer, Carlo Toniatti is featured in the Medicine Maker’s Power List

Carlo joins other leading authorities in drug discovery and development as part of the Biopharmaceuticals category in the Medicine Maker Power List. In his interview he reviews future trends in drug development and some of the defining moments of his career.

Read the article in full here

Related Posts

IRBM GEN Cell Imaging
IRBM GEN Cell Imaging
This month Genetic Engineering & Biotechnology News features IRBM in an article about ‘Image-based high-content screening and predictive cell-based assays for drug discovery and development.’
Oligomerization, Albumin Binding And Catabolism Of Therapeutic Peptides In The Subcutaneous Compartment: An Investigation On Lipidated GLP-1 Analogs
Oligomerization, albumin binding and catabolism of therapeutic peptides in the subcutaneous compartment: an investigation on lipidated GLP-1 analogs
We are delighted to publish our first paper of 2022 in the Journal of Pharmaceutical and Biomedical Analysis (Elsevier). Here we leveraged our peptide #ADME toolbox to gain a better understanding of the interplay between oligomerization, albumin binding and catabolism of lipidated peptides in the subcutaneous compartment, using #GLP-1 analogs as model peptides.
Back To Top